The SyMRI 15 has undergone rigorous clinical validation. Credit: Cision / SyntheticMR.

SyntheticMR has secured CE marking for version 15 of its next-generation imaging solution, SyMRI Neuro.

The SyMRI 15 builds upon the previous SyMRI 3D (14) and introduces images that match the diagnostic capabilities of conventional methods.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This imaging solution includes a host of advanced applications integrated into SyMRI’s post-processing suite and is set to transform the medical imaging landscape.

It has undergone rigorous clinical validation in a large multi-centre study across prominent US institutes, demonstrating that SyMRI 3D can effectively replace traditional 3D images, thereby improving efficiency and throughput.

These findings also reinforce the diagnostic accuracy of the solution.

In addition to enhanced imaging capabilities, SyMRI 15 introduces tools designed to facilitate efficient patient monitoring. These tools provide contrast-weighted images and quantitative data.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

SyntheticMR CEO Ulrik Harrysson said: “This next generation of SyMRI 3D delivers unparalleled resolution and accuracy in brain imaging, transforming the field of medical diagnostics.”

Philips Healthcare has secured an exclusive agreement to distribute SyMRI 15 globally.

This partnership ensures that SyMRI 3D will be available in Philips’ worldwide price book, allowing the company to offer a complete imaging package to its customers.

SyntheticMR developed SyMRI, delivering several, adjustable contrast images and quantitative data from one five-minute scan.

SyMRI NEURO has been designed to deliver several tissue segmentations, contrast images and quantitative data on the brain.

This solution received a CE mark and 510(k) clearance from the US Food and Drug Administration.

The company is engaged in developing and marketing software solutions for magnetic resonance imaging (MRI).

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact